Emily Bodnar Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Emily Bodnar

Stock Analyst at HC Wainwright & Co.

(2.6)
# 3170
Out of 5,459 analysts
350
Total ratings
Success rate
Average return
36 Stocks
Name Action PT Current % Upside Ratings Updated
BCTX BriaCell Therapeutic...
Maintains: Strong Buy
32 40
7.6 426.32% 15 Aug 27, 2025
INKT MiNK Therapeutics
Upgrades: Buy
35 35
15.98 119.02% 14 Aug 15, 2025
VTVT vTv Therapeutics
Reiterates: Buy
36 36
15.56 131.36% 2 Aug 13, 2025
FEMY Femasys
Maintains: Buy
12 8
n/a n/a 25 Aug 11, 2025
CNTX Context Therapeutics
Maintains: Buy
5 4
0.86 365.12% 12 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 9
2.12 324.53% 2 Jul 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 27
11.65 131.76% 2 Jul 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 20
2.9 589.66% 10 Jul 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
36 36
5.24 587.02% 9 Jul 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
115 115
69.9 64.52% 13 Jun 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
12
3.27 266.97% 1 Jun 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
25
4.54 450.66% 18 Jun 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
22 38
20.4 86.27% 10 Jun 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30 30
5.74 422.65% 20 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
3.37 226.41% 11 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
560 280
10.05 2686.07% 17 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
1.78 349.44% 6 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12 12
1.68 614.29% 13 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30 30
3.64 724.18% 7 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
19 19
1.36 1297.06% 12 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
18 18
2.24 703.57% 15 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
183 183
5.94 2974.24% 12 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
0.76 821.05% 14 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 5 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
24
10.58 126.84% 5 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
58 58
39.27 47.7% 1 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
18 18
1.1 1536.36% 1 Feb 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 15 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
38 38
11.9 219.33% 18 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
8 6
2.27 164.32% 13 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
33 33
2.22 1386.49% 14 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 1 Apr 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
13 10
10.25 -2.44% 6 Dec 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
48
47.55 0.95% 8 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
n/a n/a 1 Apr 13, 2022